tiprankstipranks
Trending News
More News >
Kringle Pharma, Inc. (JP:4884)
:4884
Japanese Market

Kringle Pharma, Inc. (4884) Income Statement

Compare
0 Followers

Kringle Pharma, Inc. Income Statement

Last quarter (Q1 2025), Kringle Pharma, Inc.'s total revenue was ¥18.16M, a decrease of -2.83% from the same quarter last year. In Q1, Kringle Pharma, Inc.'s net income was ¥-212.68M. See Kringle Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
¥ 80.04M¥ 69.25M¥ 391.83M¥ 289.76M¥ 467.62M
Gross Profit
¥ 80.04M¥ 69.25M¥ 303.42M¥ 218.16M¥ 467.62M
Operating Expenses
¥ 897.92M¥ 958.01M¥ 729.58M¥ 576.04M¥ 639.22M
Depreciation and Amortization
¥ 817.00M¥ 0.00¥ 426.00M¥ -1.00K¥ 172.00M
EBITDA
¥ -817.88M¥ -888.76M¥ 0.00¥ -299.67M¥ 0.00
Operating Income
¥ -817.88M¥ -888.76M¥ -426.17M¥ -357.88M¥ -171.60M
Other Income/Expenses
¥ 62.92M¥ 36.10M¥ 95.83M¥ 58.20M¥ 55.26M
Pretax Income
¥ -754.96M¥ -852.66M¥ -330.34M¥ -299.68M¥ -116.34M
Net Income
¥ -756.45M¥ -854.15M¥ -331.83M¥ -301.17M¥ -117.83M
Per Share Metrics
Basic EPS
¥ -118.21¥ -158.46¥ -68.33¥ -72.51¥ -106.70
Diluted EPS
¥ -118.21¥ -158.46¥ -68.33¥ -72.51¥ -106.70
Weighted Average Shares Outstanding
6.40M 5.39M 4.86M 4.15M 1.10M
Weighted Average Shares Outstanding (Diluted)
6.40M 5.39M 4.86M 4.15M 1.10M
Currency in JPY

Kringle Pharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis